Sürdürülebilir Kalkınma Amaçları
Bu dergideki yayınlar
2 →- MakaleAçık Erişim2025Scopus SJRQ2Relation between monocyte to high-density lipoprotein cholesterol ratio and prognosis in recipients after liver transplantation
Okutan, Serafettin; Saritas, Hasan; Saritas, Serdar; Bulbuloglu, Semra; Guneş, Hüseyin
Background: The end-stage liver diseases require liver transplantation as the life-saving solution. It is known that monocytes/macrophages and high-density lipoprotein cholesterol (HDLC) have important contributions to the development of hepatic inflammation and oxidative stress before liver transplantation. However, the effect of monocyte/HDL-C ratio (MHR) on clinical progression and outcome in the post-transplant period are not fully understood. Our hypothesis is that the MHR value may be associated with poor vs. good outcomes after liver transplantation. Methods: In our retrospective study, we included 464 liver transplant recipients. Patients' data were extracted from electronic and other paper records in our teaching/research hospital. The MHR values and other blood parameters (creatinine, total protein, albumin, etc.) were expressed as a mean and standard deviation, which were analyzed by the Pearson correlation test. The relationship between graft dysfunction and MHR was determined by ROC curve analysis. Results: The mean age of liver transplant recipients was 45.8 ± 13.7 years. Nineteen percent of patients had liver failure due to Alcoholic Fatty Liver Disease (AFLD) and 34.5 % had liver failure due to hepatitis B virus. At the end of 3 months after liver transplantation, 84.5 % of liver transplant recipients were alive, 5.8 % experienced graft rejection and 5.17 % had an infection. There was a statistically significant improvement in total protein, albumin, liver function tests, and serum creatinine values of the survivors (all p < 0.05). The MHR levels were significantly higher in patients who died after transplantation in comparison to those who survived before and after liver transplantation and these differences were statistically significant (p < 0.01). Conclusion: The increased MHR values of recipients after liver transplantation correlated with their risk of survival. Furthermore, the MHR value increased with increased MELD score and the number of days of hospitalization and was not affected by gender and age. MHR was higher in patients with chronic diseases. Patients with high MHR before and after transplantation should be monitored more closely in the perioperative period.
- MakaleAçık Erişim2022Scopus SJRQ3Investigation of adherence to immunosuppressive therapy and spiritual well-being in liver recipients
Gunes, Hüseyin; Bulbuloglu, Semra; Saritaş, Serdar
Objective: In our study, we investigated the relationship between spiritual well-being and adherence to immunosuppressive therapy after liver transplantation. Method: We conducted this descriptive and cross-sectional study with the participation of 131 liver transplant recipients after they had received their transplants. Data collection was carried out using a Personal Information Form, the Spiritual Well-Being Scale and the Immunosuppressant Therapy Adherence Scale. The IBM Statistical Package for the Social Sciences 25.0 was used for the statistical analyses. Results: While 73.3% of the patients were at the ages of 45–64, 72.5% were male, and 39.7% had been using immunosuppressive medication for a period between 6 months and 1 year. The rate of corticosteroid use among the patients was 30.5%, and the rate of antimetabolite use was 21.4%. A positive and significant relationship was found between adherence to immunosuppressive treatment and spiritual well-being (B = 0.425, p = 0.017). Conclusion: Spiritual well-being is an inexpensive, effective and easy strategy to increase adherence to immunosuppressive treatment. Awareness should be raised in physicians and nurses about the importance of spiritual well-being, and they should be encouraged to support spiritual well-being.
AtıfScopus5WoS6OpenAlex9İncele
Tam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| creativeworkseries.issn | 0966-3274 | |
| dc.date.accessioned | 2026-10-29T19:08:13.173169366Z | |
| dc.date.available | 2026-10-29T19:08:13.173169366Z | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/bayburt/11278 | |
| dc.publisher | Elsevier B.V. | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.title | Transplant Immunology |

